GlassScriptPhysician profile
Stephanie Phan
NPI 1639664717
$409.55
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.58 · 2023: $75.93 · 2024: $78.68 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $102.07 | 2022-2025 | Bexsero, Rotarix, Pediarix |
| Exact Sciences Corporation | $97.85 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $57.45 | 2023-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Daiichi Sankyo INC. | $36.64 | 2022-2023 | Injectafer |
| Kyowa Kirin, INC. | $22.28 | 2023 | Crysvita |
| Abbvie INC. | $20.14 | 2024 | |
| Aurinia Pharma U.S., INC. | $19.42 | 2022 | |
| Abiomed | $18.64 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.78 | 2024 | |
| Sobi, INC | $17.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.